Jia Jie Biomedical Co., Ltd.(TW:4109)
NT$10.25+0.05 (+0.49%)
TW:4109
Jia Jie Biomedical Co., Ltd. financials statements
NT$10.25
At close:+0.05 (+0.49%)
Jia Jie Biomedical Co., Ltd. (4109) Income Statement
Jia Jie Biomedical Co., Ltd. Income Statement
Last quarter (Q2 2026), Jia Jie Biomedical Co., Ltd.'s total revenue was NT$132.99M, an increase of 25.46% from the same quarter last year. In Q2, Jia Jie Biomedical Co., Ltd.'s net income was NT$-52.80M. See Jia Jie Biomedical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 485.40M | NT$ 537.07M | NT$ 332.76M | NT$ 317.72M | NT$ 242.48M | |
| NT$ 150.34M | NT$ 173.35M | NT$ 117.64M | NT$ 116.51M | NT$ 83.77M | |
| NT$ 149.63M | NT$ 140.13M | NT$ 183.84M | NT$ 130.90M | NT$ 85.00M | |
| Depreciation and Amortization | NT$ 17.53M | NT$ 15.80M | NT$ 14.89M | NT$ 16.86M | NT$ 13.44M |
| NT$ 18.24M | NT$ 241.93M | NT$ 161.30M | NT$ 12.12M | NT$ 18.58M | |
| NT$ 710.00K | NT$ 33.22M | NT$ -66.20M | NT$ -5.28M | NT$ 5.05M | |
| NT$ 59.15M | NT$ 192.26M | NT$ 212.75M | NT$ 9.00M | NT$ 6.22M | |
| NT$ 59.86M | NT$ 225.49M | NT$ 146.55M | NT$ -4.68M | NT$ 5.29M | |
| NT$ 50.26M | NT$ 211.37M | NT$ 144.15M | NT$ -5.47M | NT$ 5.34M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.43 | NT$ 2.10 | NT$ 1.62 | NT$ -0.06 | NT$ 0.06 |
| Diluted EPS | NT$ 0.43 | NT$ 2.08 | NT$ 1.62 | NT$ -0.06 | NT$ 0.06 |
| Weighted Average Shares Outstanding | 121.21M | 100.66M | 88.98M | 88.94M | 88.94M |
| Weighted Average Shares Outstanding (Diluted) | 121.21M | 100.90M | 89.19M | 88.94M | 88.94M |
Currency in TWD
